WALNUT CREEK, Calif.–(BUSINESS WIRE)–DayTwo, the chief in precision vitamin with the world’s largest and highest decision microbiome discovery platform, provides an efficient program that achieves sustained weight reduction and discount in Body Mass Index (BMI) for adults who’re overweight and for these with metabolic illness. This excessive tech, excessive contact answer equips members with exact vitamin suggestions utilizing intestine profiling, synthetic intelligence, and medical help to stabilize their blood sugar response to any meals or meals mixture, primarily based on their particular person microbiome evaluation. Unlike different packages, the DayTwo answer doesn’t require a person to take away any meals teams, resembling carbohydrates, from their food regimen. DayTwo is asserting these medical outcomes prematurely of World Microbiome Day on June 27.
DayTwo’s distinctive answer for metabolic illness has significant and sustained medical outcomes for employers, well being methods, and well being plans enabling a path to remission. After one 12 months, contributors maintain exceptional outcomes together with a mean of:
- 19 lbs of weight reduction, and
- 3.3 level drop in BMI.
- 85% of contributors misplaced greater than 10 lbs, and
- 54% of contributors lowered or eradicated prescription drugs.
DayTwo’s precision vitamin answer is obtainable at a important time, as charges of weight problems proceed to skyrocket within the U.S. The most up-to-date Centers for Disease Control and Prevention (CDC) knowledge estimates that 42% of grownup Americans are overweight.1 Common comorbidities for weight problems embody coronary heart illness, stroke, diabetes, and elevated danger for sure varieties of most cancers.
Recent options for weight problems are targeted on the usage of drugs. Wegovy (also referred to as Semaglitude), an FDA permitted drug, is estimated to value $1,300 per 30 days, making it and different prescription drugs prefer it inaccessible to many sufferers as a result of value. For these sufferers with sure coexisting metabolic circumstances like diabetes, value will be much more of a barrier. The worth of insulin has risen sharply (an estimated enhance of 43 occasions the speed of inflation), and the paired prices are sometimes prohibitive.2
DayTwo’s meals as medication answer is a confirmed revolutionary strategy for its 75,000 members. DayTwo’s protocol is predicated on scientific discoveries that individuals reply otherwise to the identical meals. Using microbiome profiling and a singular synthetic intelligence-based algorithm, blood sugar response to meals and meals combos will be precisely predicted. This is a totally totally different strategy from conventional inhabitants well being packages, which usually give attention to monitoring, one-size-fits-all, or carb elimination diets.
“Our meals as medication strategy is how we’ll flip the tide on weight problems and metabolic illness on this nation. Our sustained weight reduction and BMI discount outcomes present that we’re serving to workers attain a wholesome weight and get off costly drugs,” mentioned Josh Stevens, president of DayTwo. “By providing an efficient different to drugs and leveraging the predictive energy of a person’s intestine microbiome, we’re seeing the life altering and life saving outcomes of precision vitamin. In addition, our science permits contributors to proceed consuming meals which might be a part of their lives and cultures. Employers, well being methods, and well being plans can now supply a confirmed path to remission of power circumstances to their workers, sufferers, and members.”
Read extra in regards to the influence of metabolic illness within the U.S. here.
DayTwo, the chief in precision vitamin with the world’s largest and highest decision microbiome discovery platform, provides a sustainable path to remission for metabolic illness (diabetes, prediabetes, medical weight problems, and non-alcoholic fatty liver illness). Metabolic illness is the primary situation to be addressed by DayTwo’s microbiome discovery platform.
The firm’s answer consists of intestine microbiome profiling, synthetic intelligence to foretell blood sugar response to meals, and devoted digital care. The firm’s outcomes set a brand new nationwide benchmark for diabetes and metabolic illness care — with important sustained medical ends in lowering A1C, enhancing Time in Range, and lowering or eliminating prescription drugs. DayTwo’s scientific analysis is cited by the National Institutes of Health as a foundational component in its 10 12 months, $150 million strategic plan for precision vitamin.
To study extra about DayTwo and its options for power illness, go to www.daytwo.com.